| Literature DB >> 35522388 |
Nicole C Deziel1, Cassandra J Clark2, Joan A Casey3, Michelle L Bell4, Desiree L Plata5, James E Saiers4.
Abstract
PURPOSE OF REVIEW: Epidemiologic studies have observed elevated health risks in populations living near unconventional oil and gas development (UOGD). In this narrative review, we discuss strengths and limitations of UOG exposure assessment approaches used in or available for epidemiologic studies, emphasizing studies of children's health outcomes. RECENTEntities:
Keywords: Children’s health; Epidemiologic studies; Exposure assessment; Unconventional oil and gas
Mesh:
Year: 2022 PMID: 35522388 PMCID: PMC9363472 DOI: 10.1007/s40572-022-00358-4
Source DB: PubMed Journal: Curr Environ Health Rep ISSN: 2196-5412
Strengths and limitations of UOGD exposure assessment methods for use in health studies
| Exposure assessment method | Summary | Strengths | Limitations |
|---|---|---|---|
| Survey methods | Questionnaires, surveys, or interviews may be used to collect individual-level exposure information | Comparatively inexpensive Can be administered to many participants Can gather information on a wide variety of exposures and exposure-related factors Can ask about present and past behaviors and exposures Can gauge participants’ perceptions of exposure | Cannot capture exposures that are not known or observable to participants (e.g., chemical stressors) with precision or specificity Provides mainly qualitative information Information provided by participants may be subject to bias (e.g., recall bias), and retrospective information may be inaccurate |
| Aggregate proximity-based models and metrics | Distance and density-based mathematical models that assume exposure to UOGD varies in a predictable and consistent way in relation to proximity to source | Easily scalable for large studies Comparatively inexpensive Provides aggregate measure of exposure when etiologic agent is not known Often use publicly available information Can be used retrospectively or to align with etiologic windows of interest | Cannot separate individual etiologic agents or routes of exposure May not capture all routes of exposure (e.g., water) well or equally Based upon the assumption that UOG exposure varies in a predictable and consistent way in relation to proximity to source Does not address differences in exposures due to behaviors and activities May not reflect true patterns of environmental stressors (e.g., hydrologic patterns in comparison to buffer distance) |
| Pathway-specific models and metrics | Models designed to capture one or more specific exposure pathways (e.g., flaring, air pollution, radioactive material) | Scalable for large studies Comparatively inexpensive May provide more precise estimates than general spatial models when etiologic agent or pathway of concern is known Often use publicly available information Can be used retrospectively or to align with etiologic windows of interest | Generally requires large amounts of specific data that may not be available in all locations Computationally intensive Models have varying sources of error to account for (e.g., for the flaring model, double-counting of edge pixels in satellite imagery) |
| Environmental measurements | Quantification of UOG-related chemicals, elements, or compounds in air, water, soil, or other environmental media. Includes area monitoring and direct personal monitoring | Provides information on both location and magnitude of exposure Provides objective and quantitative measurements of specific etiologic agents Measurements may be incorporated into models and used to validate or improve models Repeated measurements may be used to quantify duration of exposure and temporal variations | Expensive and logistically difficult for large-scale studies (e.g., equipment, cost/comprehensiveness tradeoffs, strict protocols when interacting with human subjects) Chemicals used or produced not all known Nearly impossible to capture the numerous potential contaminants across the various media Timing sampling to coincide with intermittent or localized exposures (e.g., spills, release of air pollutants during peak production) is difficult and relies on timely and publicly available reporting of incidents Sampling at one point in time is unlikely to accurately represent long-term exposures Environmental measurements may not be reflective of individual exposure |
| Biological monitoring | Measurements of UOG-related chemicals, elements, or compounds in biologic media (e.g., urine, blood, hair) | Provides integrated measure of exposure from multiple pathways Accurate measure of individual-level exposure | Collection of biosamples requires participant cooperation and consent, strict adherence to ethical guidelines and protocols, and sample collectors trained in the necessary techniques (e.g., phlebotomy) Expensive Etiologic agent(s) must be known, and the large range of UOG-related compounds makes targeted biomonitoring challenging Biomarkers are not available for all contaminants Etiologic agents have varying half-lives, and a one-time measurement may not reflect long-term exposure Does not provide information on the source or route of exposure |
Fig. 1Characteristics of unconventional oil and gas development exposure assessment methods. The location of the icon indicates where each method lies on a spectrum of the respective characteristics
Features and applications of UOG exposure assessment methods in studies of UOGD and health outcomes
| UOG exposure assessment methoda | Description of exposure assessment | Lead author (year) by study endpoints | |||
|---|---|---|---|---|---|
| Adverse perinatal outcomes ( | Hospitalizations, asthma, cardiovascular diseases, or mortality ( | Cancer ( | Other health outcomesb ( | ||
| Aggregate proximity-based metrics and models | |||||
| Presence or number of wells or permits per zip code, county, or other geographic unit | Area-based count density; number of wells per a specified area or administrative boundary | Ma (2016)* [ Tran (2021)* [ Busby (2017)* [ Tang (2021)* [ Tran (2020)*,c [ Apergis (2019)* [ Hill (2018)* [ Hill (2022)* [ | Jemielita (2015)* [ Willis (2018)* [ Denham (2019)* [ Denham (2021) [ Willis (2020)*,c [ Peng (2018)* [ Johnston (2021) [ | Fryzek [ Finkel [ | Deziel (2018) [ Komarek (2017) [ Johnson (2020) [ |
| Distance to UOG well | Geographic distance between residence and nearest UOG well | Currie (2017)* [ Willis (2021)* [ | Koehler (2018)c [ | ||
| Inverse distance weighted well count | A count of all wells within a prescribed area around a home (i.e., buffer) that gives more weight to wells located closer. May be intensity-adjusted or phase-specific | Stacy (2015)* [ McKenzie (2014)* [ Whitworth (2018)* [ Whitworth (2017)* [ Janitz (2019)* [ Caron-Beaudoin (2021)* [ | Koehler (2018)c [ Li (2022) [ | McKenzie (2017)* [ | |
| Inverse distance-squared weighted | A count of all wells within a prescribed area around a home (i.e., buffer) that gives more weight to wells located closer. Assumes that the exposure potential declines rapidly with distance, as a function of the distance squared | González (2020)* [ | |||
| Activity-based metric | A count of all wells within a prescribed area around a home that gives more weight to wells located closer. Assumes that the exposure potential declines rapidly with distance, as a function of the distance squared. Assumes that each phase of well development has different exposure potential that may be represented by features of the well (e.g., total well depth, daily natural gas production volume) | Casey (2016)* [ Casey (2019)* [ Tran (2020)*,c [ | McAlexander (2020) [ Koehler (2018) [ Rasmussen (2016)* [ Willis (2020)*,c [ | Tustin (2016) [ Casey (2018) [ | |
| Pathway-specific models and metrics | |||||
| Air pathway | McKenzie (2019a)* [ | McKenzie (2019b) [ Li (2022) [ | |||
| Flaring | Cushing [ | Willis (2020) [ | |||
*Indicates a study with a pediatric population or a population that includes both children and adults with results presented separately for children
aNote that no epidemiologic studies included in this review used surveys, environmental measurements, or biological monitoring to assess exposure to UOGD
bOther health outcomes includes studies of self-reported health symptoms, mental health outcomes, nasal/sinus symptoms, fatigue, migraine, and sexually transmitted infections
cThis study applied multiple metrics that fit into multiple categories